Insilico Medicine Raises $123 Million with Oversubscribed Series E Funding Round
Cambridge, MA — In an impressive demonstration of investor confidence and technological promise, Insilico Medicine, a trailblazing clinical-stage biotech company ...
Cambridge, MA — In an impressive demonstration of investor confidence and technological promise, Insilico Medicine, a trailblazing clinical-stage biotech company ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine